Safety of vaccination of patients with systemic lupus erythematosus

被引:24
作者
Abu-Shakra, M. [1 ,2 ]
机构
[1] Soroka Med Ctr, Dept Med, Rheumat Dis Unit, IL-84101 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel
关键词
Vaccination; SLE; influenza; autoantibodies; SLEDAI; INFLUENZA-VIRUS VACCINATION; HEPATITIS-B VACCINATION; RHEUMATOID-ARTHRITIS; ANTIBODY-RESPONSES; IMMUNIZATION; EFFICACY; DISEASE; SLE; AUTOANTIBODIES; AUTOIMMUNITY;
D O I
10.1177/0961203309346507
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Live vaccines are not safe for immuno-compromised patients and should not be given to patients with systemic lupus erythematosus. In addition, all vaccines are not recommended for systemic lupus erythematosus patients when their disease is very active and mainly for patients with very active lupus nephritis. Systemic lupus erythematosus patients with quiescent or mildly active disease should be encouraged to receive vaccination according the recommendations given by the Immunization Practices Advisory Committee. Among this group of systemic lupus erythematosus patients, vaccines are safe and they do not affect the clinical manifestations of systemic lupus erythematosus including renal features, disease activity, or the requirement for steroids or cytotoxic drugs. However, vaccines may trigger the generation of autoantibodies which is usually short term and has no clinical significance. In individual cases vaccines exacerbate systemic lupus erythematosus; however, no specific clinical or laboratory variables have been identified to be associated with flare of systemic lupus erythematosus following vaccination. Lupus (2009) 18, 1205-1208.
引用
收藏
页码:1205 / 1208
页数:4
相关论文
共 28 条
[1]   Mortality studies in SLE: how far can we improve survival of patients with SLE [J].
Abu-Shakra, M ;
Gladman, DD ;
Urowitz, MB .
AUTOIMMUNITY REVIEWS, 2004, 3 (06) :418-420
[2]  
Abu-Shakra M, 2002, J RHEUMATOL, V29, P2555
[3]   Influenza virus vaccination of patients with SLE: Effects on generation of autoantibodies [J].
Abu-Shakra, M ;
Press, J ;
Sukenik, S ;
Buskila, D .
CLINICAL RHEUMATOLOGY, 2002, 21 (05) :369-372
[4]  
Abu-Shakra M, 2000, J RHEUMATOL, V27, P1681
[5]  
ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259
[6]  
AROMMAOR A, 2007, LUPUS, V10, P237
[7]  
Battafarano DF, 1998, ARTHRITIS RHEUM, V41, P1828, DOI 10.1002/1529-0131(199810)41:10<1828::AID-ART15>3.3.CO
[8]  
2-K
[9]   INFLUENZAL VACCINE RESPONSE IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BRODMAN, R ;
GILFILLAN, R ;
GLASS, D ;
SCHUR, PH .
ANNALS OF INTERNAL MEDICINE, 1978, 88 (06) :735-740
[10]   Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis -: Safety and immunogenicity [J].
Del Porto, F ;
Laganà, B ;
Biselli, R ;
Donatelli, I ;
Campitelli, L ;
Nisini, R ;
Cardelli, P ;
Rossi, F ;
D'Amelio, R .
VACCINE, 2006, 24 (16) :3217-3223